Sarit Assouline, Nancy Bartlett, Laurie Sehn, Pratyush Giri, John Kuruvilla, Stephen Schuster, Sung-Soo Yoon, Keith Fay, Georg Hess, Martin Dreyling, Norma Gutierrez, Eva Cybulski, Fidelis Sabalvaro, Elicia Peneul, Samuel Tracy, Denison Kuruvilla, Joseph Chen, Volker Wiebking, Michael C. Wei, Elizabeth Budde. "Fixed-duration subcutaneous mosunetuzumab continues to demonstrate high rates of durable responses in patients with relapsed/refractory follicular lymphoma after ≥2 prior therapies: 3-year follow-up from a pivotal Phase II study." Blood, 2025. doi:10.1182/blood-2025-5353